Source: Nano Letters. Unidade: EEL
Subjects: FÁRMACOS, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZHU, Jundong et al. Upconverting Nanocarriers Enable Triggered Microtubule Inhibition and Concurrent Ferroptosis Induction for Selective Treatment of Triple-Negative Breast Cancer. Nano Letters, v. 20, n. 9, p. 6235-6245, 2020Tradução . . Disponível em: https://doi.org/10.1021/acs.nanolett.0c00502. Acesso em: 27 nov. 2025.APA
Zhu, J., Wang, Z., Zhao, Y., Dai, P., Liu, F., Li, Y., et al. (2020). Upconverting Nanocarriers Enable Triggered Microtubule Inhibition and Concurrent Ferroptosis Induction for Selective Treatment of Triple-Negative Breast Cancer. Nano Letters, 20( 9), 6235-6245. doi:10.1021/acs.nanolett.0c00502NLM
Zhu J, Wang Z, Zhao Y, Dai P, Liu F, Li Y, Qin Y, Yang Q, Tian R, Fan A, Medeiros S de F. Upconverting Nanocarriers Enable Triggered Microtubule Inhibition and Concurrent Ferroptosis Induction for Selective Treatment of Triple-Negative Breast Cancer [Internet]. Nano Letters. 2020 ; 20( 9): 6235-6245.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1021/acs.nanolett.0c00502Vancouver
Zhu J, Wang Z, Zhao Y, Dai P, Liu F, Li Y, Qin Y, Yang Q, Tian R, Fan A, Medeiros S de F. Upconverting Nanocarriers Enable Triggered Microtubule Inhibition and Concurrent Ferroptosis Induction for Selective Treatment of Triple-Negative Breast Cancer [Internet]. Nano Letters. 2020 ; 20( 9): 6235-6245.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1021/acs.nanolett.0c00502
